In a six-month study patients who were found to be depressed had a 7% increased chance of dying and this percentage increased depending on the severity of the depression. Depression is common in patients with advanced cancer and in a significant number of patients it is persistent.
The researchers examined symptoms and mood in patients using a screening method originally devised for postnatal mothers, containing questions on worthlessness, subjective sadness and suicidal thoughts as well as questions about symptoms and pain. Depression affected 29% of patients at the initial screening and 54.5% of surviving patients remained depressed eight weeks later.
Professor Mari Lloyd-Williams from the School of Population, Community and Behavioural Sciences said: “Previous research has shown that stroke patients who were depressed did not regain function as well as other patients and they had a higher risk of dying – all patients who have suffered a stroke are now screened for depression but this is not the case for patients at any stage of cancer.
“We know that a patient’s mental state affects their physical state but not enough is known about why this happens. We believe that when someone is depressed they lose motivation and therefore the will to live.
“Depression affects 25% of patients with advanced cancer but at this stage it is difficult to diagnose. Whilst patients with advanced cancer are clearly very ill they can still be effectively treated for depression but the first step in the treatment is the recognition that the patient is depressed.”
Professor Lloyd-Williams and her team have been awarded £2.5 million to carry out further research in palliative care. They are currently working on a larger study of more than 400 patients to identify what emotional and psychological health problems cancer patients experiencing in order to better understand their mental health needs and how to improve their primary care.
Charlotte Roberts | alfa
Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University
New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
On 15 March, the AWI research aeroplane Polar 5 will depart for Greenland. Concentrating on the furthest northeast region of the island, an international team...
The world’s second-largest ice shelf was the destination for a Polarstern expedition that ended in Punta Arenas, Chile on 14th March 2018. Oceanographers from...
At the 2018 ILA Berlin Air Show from April 25–29, the Fraunhofer Institute for Laser Technology ILT is showcasing extreme high-speed Laser Material Deposition (EHLA): A video documents how for metal components that are highly loaded, EHLA has already proved itself as an alternative to hard chrome plating, which is now allowed only under special conditions.
When the EU restricted the use of hexavalent chromium compounds to special applications requiring authorization, the move prompted a rethink in the surface...
At the ILA Berlin, hall 4, booth 202, Fraunhofer FHR will present two radar sensors for navigation support of drones. The sensors are valuable components in the implementation of autonomous flying drones: they function as obstacle detectors to prevent collisions. Radar sensors also operate reliably in restricted visibility, e.g. in foggy or dusty conditions. Due to their ability to measure distances with high precision, the radar sensors can also be used as altimeters when other sources of information such as barometers or GPS are not available or cannot operate optimally.
Drones play an increasingly important role in the area of logistics and services. Well-known logistic companies place great hope in these compact, aerial...
16.03.2018 | Event News
13.03.2018 | Event News
08.03.2018 | Event News
16.03.2018 | Earth Sciences
16.03.2018 | Physics and Astronomy
16.03.2018 | Life Sciences